Pharvaris N.V. (PHVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 46,364 | 45,832 | 44,443 | 48,208 | 41,677 |
| Operating Income | -46,364 | -45,832 | -44,443 | -48,208 | -41,677 |
| Interest Expense | 0 | 5,568 | 4,058 | 0 | 3,935 |
| Other Income | 2,742 | 0 | 0 | 12,605 | 0 |
| Pre-tax Income | -43,622 | -51,400 | -48,501 | -35,602 | -45,612 |
| Income Tax | -212 | 230 | 319 | 1,336 | 253 |
| Net Income Continuous | -43,410 | -51,630 | -48,820 | -36,939 | -45,865 |
| Net Income | $-43,410 | $-51,630 | $-48,820 | $-36,939 | $-45,865 |
| EPS Basic Total Ops | -0.70 | -0.94 | -0.90 | -0.68 | -0.85 |
| EPS Basic Continuous Ops | -0.70 | -0.94 | -0.90 | -0.68 | -0.85 |
| EPS Diluted Total Ops | -0.70 | -0.94 | -0.90 | -0.68 | -0.85 |
| EPS Diluted Continuous Ops | -0.70 | -0.94 | -0.90 | -0.68 | -0.85 |
| EPS Diluted Before Non-Recurring Items | -0.70 | -0.94 | -0.89 | -0.68 | -0.85 |
| EBITDA(a) | $-46,234 | $-45,706 | $-44,332 | $-48,112 | $-41,626 |